Lowe Brockenbrough & Co. Inc. decreased its stake in UnitedHealth Group Incorporated (NYSE:UNH) by 0.1% during the first quarter, according to its most recent disclosure with the SEC. The firm owned 43,854 shares of the healthcare conglomerate’s stock after selling 40 shares during the period. UnitedHealth Group comprises approximately 1.1% of Lowe Brockenbrough & Co. Inc.’s holdings, making the stock its 27th largest position. Lowe Brockenbrough & Co. Inc.’s holdings in UnitedHealth Group were worth $7,192,000 as of its most recent SEC filing.

Several other large investors have also modified their holdings of the company. State Street Corp boosted its position in shares of UnitedHealth Group by 2.5% in the first quarter. State Street Corp now owns 45,724,509 shares of the healthcare conglomerate’s stock worth $7,499,276,000 after buying an additional 1,122,534 shares in the last quarter. Legal & General Group Plc boosted its position in shares of UnitedHealth Group by 5.4% in the first quarter. Legal & General Group Plc now owns 4,954,692 shares of the healthcare conglomerate’s stock worth $812,630,000 after buying an additional 254,545 shares in the last quarter. Harris Associates L P boosted its position in shares of UnitedHealth Group by 0.3% in the first quarter. Harris Associates L P now owns 4,646,307 shares of the healthcare conglomerate’s stock worth $762,041,000 after buying an additional 14,489 shares in the last quarter. UBS Asset Management Americas Inc. boosted its position in shares of UnitedHealth Group by 6.2% in the first quarter. UBS Asset Management Americas Inc. now owns 4,372,898 shares of the healthcare conglomerate’s stock worth $717,199,000 after buying an additional 255,799 shares in the last quarter. Finally, American Century Companies Inc. boosted its position in shares of UnitedHealth Group by 9.0% in the first quarter. American Century Companies Inc. now owns 4,022,002 shares of the healthcare conglomerate’s stock worth $659,649,000 after buying an additional 333,338 shares in the last quarter. Institutional investors own 86.21% of the company’s stock.

Shares of UnitedHealth Group Incorporated (UNH) traded up 0.24% during mid-day trading on Monday, hitting $193.49. 652,128 shares of the stock were exchanged. UnitedHealth Group Incorporated has a 12-month low of $132.39 and a 12-month high of $196.04. The stock has a market capitalization of $187.08 billion, a P/E ratio of 23.24 and a beta of 0.64. The stock’s 50 day moving average price is $189.36 and its 200-day moving average price is $174.75.

UnitedHealth Group (NYSE:UNH) last posted its quarterly earnings results on Tuesday, July 18th. The healthcare conglomerate reported $2.46 earnings per share (EPS) for the quarter, beating the consensus estimate of $2.38 by $0.08. UnitedHealth Group had a net margin of 4.32% and a return on equity of 21.52%. The business had revenue of $50.05 billion during the quarter, compared to the consensus estimate of $49.97 billion. During the same quarter last year, the firm posted $1.96 EPS. UnitedHealth Group’s revenue was up 7.7% compared to the same quarter last year. On average, equities research analysts expect that UnitedHealth Group Incorporated will post $9.87 EPS for the current fiscal year.

WARNING: This piece was posted by Watch List News and is the property of of Watch List News. If you are viewing this piece on another site, it was copied illegally and republished in violation of U.S. & international copyright law. The correct version of this piece can be viewed at https://www.watchlistnews.com/lowe-brockenbrough-co-inc-has-7-19-million-stake-in-unitedhealth-group-incorporated-nyseunh/1487290.html.

A number of research analysts recently issued reports on the stock. UBS AG restated a “buy” rating and set a $194.00 price objective (up previously from $193.00) on shares of UnitedHealth Group in a report on Saturday, April 22nd. Cantor Fitzgerald restated an “overweight” rating and set a $205.00 price objective (up previously from $200.00) on shares of UnitedHealth Group in a report on Saturday, April 22nd. Sanford C. Bernstein restated an “outperform” rating and set a $190.00 price objective on shares of UnitedHealth Group in a report on Monday, July 10th. Credit Suisse Group restated an “outperform” rating and set a $200.00 price objective (up previously from $195.00) on shares of UnitedHealth Group in a report on Thursday, July 13th. Finally, Citigroup Inc. boosted their price objective on shares of UnitedHealth Group from $195.00 to $213.00 and gave the company a “buy” rating in a report on Wednesday, July 19th. One research analyst has rated the stock with a hold rating and twenty-four have given a buy rating to the company. The stock currently has an average rating of “Buy” and an average target price of $202.20.

In other UnitedHealth Group news, Director Gail R. Wilensky sold 5,540 shares of UnitedHealth Group stock in a transaction on Friday, June 2nd. The shares were sold at an average price of $178.74, for a total transaction of $990,219.60. Following the transaction, the director now directly owns 60,516 shares of the company’s stock, valued at approximately $10,816,629.84. The transaction was disclosed in a legal filing with the Securities & Exchange Commission, which is available through this hyperlink. Also, Director William C. Ballard, Jr. sold 5,000 shares of UnitedHealth Group stock in a transaction on Wednesday, June 7th. The stock was sold at an average price of $182.64, for a total transaction of $913,200.00. Following the transaction, the director now directly owns 75,735 shares in the company, valued at $13,832,240.40. The disclosure for this sale can be found here. In the last three months, insiders sold 15,540 shares of company stock valued at $2,873,320. 0.89% of the stock is currently owned by insiders.

UnitedHealth Group Company Profile

UnitedHealth Group Incorporated is a health and well-being company. The Company operates through four segments: UnitedHealthcare, OptumHealth, OptumInsight and OptumRx. It conducts its operations through two business platforms: health benefits operating under UnitedHealthcare and health services operating under Optum.

Want to see what other hedge funds are holding UNH? Visit HoldingsChannel.com to get the latest 13F filings and insider trades for UnitedHealth Group Incorporated (NYSE:UNH).

Institutional Ownership by Quarter for UnitedHealth Group (NYSE:UNH)

Receive News & Ratings for UnitedHealth Group Incorporated Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for UnitedHealth Group Incorporated and related companies with Analyst Ratings Network's FREE daily email newsletter.